Alterations in skeletal muscle structure are minimized with steroid withdrawal after renal transplantation

Transplantation

Volumn 76, Issue 4, 2003, Pages 667-673

  Topp, K S ^a,b   Painter, P L ^a   Walcott, S ^a   Krasnoff, J B ^a   Adey, D ^b   Sakkas, G K ^b   Taylor, J ^a   McCormick, K ^a   Tenyenhuis, M ^a   Iofina, M ^a   Tomlanovich, S ^b   Stock, P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; EXERCISE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIPID METABOLISM; MALE; MITOCHONDRION; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE FUNCTION; MYOFILAMENT; PRIORITY JOURNAL; SARCOLEMMA; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

ADULT; AGED; EXERCISE; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOFIBRILS; PREDNISONE;

EID: 0042337137     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000076096.45542.1B     Document Type: Article

References (29)

1. Kouidi E, Albani M, Natsis K, et al. The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 685.
2. Moore G, Brinker K, Stray-Gundersen J, et al. Determinants of VO2peak in patients with end-stage renal disease: on and off dialysis. Med Sci Sports Exerc 1993; 25: 18.
3. Moore G, Parsons D, Stray-Gundersen J, et al. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J Kidney Dis 1993; 22: 277.
4. Painter P, Messer-Rehak D, Hanson P, et al. Exercise capacity in hemodialysis, CAPD, and renal transplant patients. Nephron 1986; 42: 47.
5. Painter P, Hanson P, Messer-Rehak D, et al. Exercise tolerance changes following renal transplantation. Am J Kidney Dis 1987; 10: 452.
6. Painter P, Luetkemeier M, Moore G, et al. Health-related fitness and quality of life in organ transplant recipients. Transplantation 1997; 64: 1795.
7. Painter P, Hector L, Ray K, et al. A randomized trial of exercise training following renal transplantation. Transplantation 2002; 74: 42.
8. Kempeneers G, Noakes T, van Zyl-Smit R, et al. Skeletal muscle limits to exercise tolerance of renal transplant recipients: effects of a graded exercise training program. Am J Kidney Dis 1990; 16: 57.
9. Diesel W, Emms M, Knight B, et al. Morphologic features of the myopathy associated with chronic renal failure. Am J Kidney Dis 1993; 22: 677.
10. Danneskiold-Samsoe B, Grimby G. The influence of prednisone on the muscle morphology and muscle enzymes in patients with rheumatoid arthritis. Clin Sci 1986; 71: 693.
11. Horber F, Hoppeler H, Herren D, et al. Altered skeletal muscle ultrastructure in renal transplant patients on prednisone. Kidney Int 1986; 30: 411.
12. Horber F, Scheidegger J, Grunig B, et al. Thigh muscle mass and function in patients treated with glucocorticoids. Euro J Clin Invest 1985; 15: 302.
13. Pette D, Staron R. Myosin isoforms, muscle fiber types, and transitions. Microsc Res Tech 2000; 50: 500.
14. Meredity C, Frontera W, Fisher E, et al. Peripheral effects of endurance training in young and old subjects. Am J Physiol 1989; 66: 2844.
15. Kaminski H, Ruff R. Myology: basic and clinical. In: Engel A, Franzini-Armstrong C, eds. New York, McGraw-Hill, Inc. 1994, p 1726.
16. Schulak J, Hricik D. Steroid withdrawal after renal transplantation. Clin Transplant 1994; 8: 211.
17. Kjellstrant C. Side effects of steroids and their treatment. Transplant Proc 1975; 7: 123.
18. Dunn T, Asolati M, Holman D, et al. Long-term outcome of a prospective trial of steroid withdrawal after kidney transplantation. Surgery 1999; 125: 155.
19. Painter P, Topp K, Krasnoff J, et al. Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients. Kidney Int 2003; 63: 2309.
20. Guidelines for exercise testing and prescription. American College of Sports Medicine. Philadelphia, Williams and Wilkins 1995.
21. Bergstrom J. Muscle electrolytes in man. Scand J Clin Lab Invest 1962; 14(suppl 68): 11.
22. Brooke M, Kaiser K. Muscle fiber types: how many and what kind? Arch Neurol 1970; 23: 369.
23. Scott W, Stevens J, Binder-Macleod S. Human skeletal muscle fiber type classifications. Phys Ther 2001; 81: 1811.
24. Weibel E, Kistler G, Scherle W. Practical stereological methods for morphometric cytology. J Cell Biol 1966; 30: 23.
25. Moore R. Simulect: redefining immunosuppressive strategies. Transplant Proc 2000; 32: 1460.
26. Fahal I, Bell G, Bone J, et al. Physiological abnormalities of skeletal muscle in dialysis patients. Nephrol Dial Transplant 1997; 12: 119.
27. Wang X, Williams T, McKenna M, et al. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation. Am J Respir Crit Care Med 1999; 160: 57.
28. Golczynska A, Lenders J, Goldstein D. Glucocorticoid-induced sympathoinhibition in humans. Clin Pharmacol Ther 1995; 58: 90.
29. Ekstrand A, Schalin-Jantti C, Lofman M, et al. The effect of (steroid) immunosuppression on skeletal muscle glycogen metabolism in patients after kidney transplantation. Transplantation 1996; 61: 889.